Quality of life and Kaposi sarcoma: Using preference techniques to value the health gains from treatment

Supportive Care in Cancer

Volumn 10, Issue 6, 2002, Pages 486-493

  Harris, Anthony H ^a   Osborne, Richard H ^a   Streeton, Catherine L ^a   McNeil, Helen ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Economic evaluation; Kaposi sarcoma; Quality of life; Time trade off

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; DEATH; ECONOMIC ASPECT; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LIFE EXPECTANCY; MALE; PATIENT ATTITUDE; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; ATTITUDE TO HEALTH; CHOICE BEHAVIOR; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; QUALITY OF LIFE; SARCOMA, KAPOSI; SEVERITY OF ILLNESS INDEX;

EID: 0036940297     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-002-0363-2     Document Type: Article

References (12)

1. Levine AM, Tulpule A (2000) Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer 37:1288-1295
2. Mitsuyasu RT (2000) AIDS-related Kaposi's sarcoma: current treatment options, future trends. Oncology (Huntingt) 14:867-878
3. Dezube BJ (2000) Acquired immunodeficiency syndrome-related Kaposi's sarcoma: clinical features, staging, and treatment. Semin Oncol 27:424-443
4. Holland JC, Tross S (1987) Psychosocial considerations in the therapy of epidemic Kaposi's sarcoma. Semin Oncol 14:48-53
5. Dolan P (2000) The measurement of health-related quality of life for use in resource allocation decisions. In: Culyer AJ, Newhouse JP (eds) Handbook of health economics. Amsterdam Elsevier, pp 1723-1760
6. Drummond M, O'Brien B, Stoddard G, Torrance G (1997) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford
7. Bleichrodt H, Johannesson M (1997) An experimental test of a theoretical foundation for rating-scale valuations. Med Decis Making 17:208-216
8. Robinson A, Dolan P, Williams A (1997) Valuing health status using VAS and TTO: what lies behind the numbers? Soc Sci Med 45:1289-1297
9. Tsasis P (2000) Health-related quality-of-life measurements in HIV/AIDS care. AIDS Patient Care and STDs 14:427-438
10. Torrance G (1986) Measurement of health state utilities for economic appraisal: A review. J Health Econ 5:1-30
11. Hawthorne G, Richardson J, Day N (2001) A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med 33:358-370
12. Dolan P (1996) The effect of experience of illness on health state valuations. J Clin Epidemiol 49:551-564